WallStreetZenWallStreetZen

NASDAQ: NRXP
Nrx Pharmaceuticals Inc Stock Ownership - Who owns Nrx Pharmaceuticals?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Nrx Pharmaceuticals Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Jonathan C. JavittChairman and Chief Scientist2024-12-1740,000$1.17
$46.80kBuy

1 of 1

NRXP insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when NRXP insiders and whales buy or sell their stock.

NRXP Shareholders

What type of owners hold Nrx Pharmaceuticals Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Daniel C. Javitt119.80%23,606,657$62.32MInsider
Jonathan C. Javitt81.12%15,985,163$42.20MInsider
B Group Inc15.22%3,000,000$7.92MInsider
Chaim Hurvitz12.30%2,423,236$6.40MInsider
Brac Lending Group LLC11.31%2,228,435$5.88MInsider
Anson Funds Management LP8.14%1,604,975$4.24MInstitution
Polar Asset Management Partners Inc5.10%1,005,536$2.65MInsider
Big Rock Partners Sponsor LLC2.64%519,315$1.37MInsider
Vanguard Group Inc2.29%452,175$1.19MInstitution
Patrick John Flynn2.05%404,291$1.07MInsider

1 of 3

NRXP vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
NRXP5.67%94.33%Net Buying
CLNN1.47%98.53%Net BuyingNet Selling
MAIA6.92%15.27%Net BuyingNet Buying
PYPD18.47%0.00%
ATHE0.00%0.00%
View Top Biotech Stocks

Nrx Pharmaceuticals Stock Ownership FAQ

Who owns Nrx Pharmaceuticals?

Nrx Pharmaceuticals (NASDAQ: NRXP) is owned by 15.20% institutional shareholders, 252.73% Nrx Pharmaceuticals insiders, and 0.00% retail investors. Daniel C. Javitt is the largest individual Nrx Pharmaceuticals shareholder, owning 23.61M shares representing 119.80% of the company. Daniel C. Javitt's Nrx Pharmaceuticals shares are currently valued at $63.50M.

If you're new to stock investing, here's how to buy Nrx Pharmaceuticals stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.